Firstly, some AF patients have the comorbidities that may affect myocardial fibrosis and remodeling, such as hypertension, diabetes, and coronary heart disease, which may lead to inaccurate measurements of serum levels of Gal-3 and ALD. This evidence concerns the gene LGALS3 and Myocardial fibrosis.